The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $4.15

Today's change-0.07 -1.66%
Updated November 17 4:01 PM EST. Delayed by at least 15 minutes.
 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $4.15

Today's change-0.07 -1.66%
Updated November 17 4:01 PM EST. Delayed by at least 15 minutes.

Community Health Systems Inc down (U.S.)$0.07

Community Health Systems Inc closed sharply lower Friday, dropping (U.S.)$0.07 or 1.66% to (U.S.)$4.15. Over the last five days, shares have lost 5.25% and are down 25.76% for the last year to date. This security has underperformed the S&P 500 by 42.32% during the last year.

Key company metrics

  • Open(U.S.) $4.23
  • Previous close(U.S.) $4.22
  • High(U.S.) $4.29
  • Low(U.S.) $4.09
  • Bid / Ask(U.S.) $4.09 / (U.S.) $4.18
  • YTD % change-25.76%
  • Volume2,602,850
  • Average volume (10-day)3,636,861
  • Average volume (1-month)4,146,326
  • Average volume (3-month)3,905,969
  • 52-week range(U.S.) $3.95 to (U.S.) $10.51
  • Beta1.55
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$5.82
Updated November 17 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-3.39%

Although this company's net profit margin is negative, it is above the industry average and implies that Community Health Systems Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.40%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue3,6664,1444,4864,469
Total other revenue--------
Total revenue3,6664,1444,4864,469
Gross profit3,0563,4473,7373,739
Total cost of revenue610697749730
Total operating expense3,5804,0414,4364,394
Selling / general / administrative1,8172,0242,1702,197
Research & development--------
Depreciation / amortization206223236261
Interest expense (income), net operating--------
Unusual expense (income)3897230230
Other operating expenses, total9091,0001,051976
Operating income861035075
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-147-131-176-152
Income after tax-88-116-176-189
Income tax, total-59-15037
Net income-110-137-199-221
Total adjustments to net income--------
Net income before extra. items-108-131-198-211
Minority interest-20-15-22-22
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-108-131-198-211
Inc. avail. to common incl. extra. items-110-137-199-221
Diluted net income-110-137-199-221
Dilution adjustment----00
Diluted weighted average shares112112111111
Diluted EPS excluding extraordinary itemsvalue per share-0.96-1.17-1.78-1.90
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.74-0.610.29-0.55